US bans more products from India\\\'s Ranbaxy

 New York, Jan 24 (bbc): The US has banned India's largest drugmaker Ranbaxy from producing and distributing drugs for the US market from its Toansa facility in Punjab.
The US drug regulator said there had been "significant" manufacturing violations at the facility.
It alleged that staff had retested materials after those items had failed initial tests "in order to produce acceptable findings".
Other Ranbaxy units have also come under scrutiny by the US in the past.
The US Food and Drug Administration (FDA) has previously banned products from the company's facilities in Paonta Sahib, Dewas and Mohali.